- Previous Close
0.0120 - Open
0.0120 - Bid 0.0110 x --
- Ask 0.0120 x --
- Day's Range
0.0110 - 0.0120 - 52 Week Range
0.0100 - 0.0370 - Volume
4,420,649 - Avg. Volume
2,186,921 - Market Cap (intraday)
32.464M - Beta (5Y Monthly) 1.03
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Feb 26, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, North America, and Latin America. Its products include AnteoBind, s an activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution for the development of diagnostic tests; AnteoBind Micro and Micro Kit , a micro-particle-based assay development and bioseparation; AnteoBind Sub-Micron, Particle-based assay development and bioseparation; AnteoBind Biosensor, a planar solid phase assay development; Activation Kit Multiplex Microspheres, an immunoassay development; and Nano Kit, a nanoparticle-based lateral flow assay development and bioseparation. The company also offers AnteoX, an additive that reinforces battery binders that enhance performance of silicon containing anodes; and Ultranode, an ultra-high silicon anode design to offer high performance for lithium-ion batteries. In addition, it provides contract services. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.
www.anteotech.comRecent News: ADO.AX
View MorePerformance Overview: ADO.AX
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ADO.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ADO.AX
View MoreValuation Measures
Market Cap
32.46M
Enterprise Value
27.35M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
38.81
Price/Book (mrq)
4.21
Enterprise Value/Revenue
36.91
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-57.94%
Return on Equity (ttm)
-140.07%
Revenue (ttm)
-545.39k
Net Income Avi to Common (ttm)
-8.72M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
7.38M
Total Debt/Equity (mrq)
29.44%
Levered Free Cash Flow (ttm)
-3.71M